Navigation Links
Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
Date:11/5/2007

SANTA MONICA, Calif., Nov. 5 /PRNewswire-USNewswire/ -- Amended stem cell patent claims submitted by the Wisconsin Alumni Research Foundation don't overcome the U.S. Patent Office Examiner's rejections and the claims remain unpatentable, two consumer groups said today.

In formal comments filed Friday the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) asked that the rejections first issued on March 30 by the U.S. PTO be made final.

"Stem cell science would be best served if WARF simply withdrew their overreaching claims," said John M. Simpson, FTCR's stem cell project director.

In July 2006 the FTCR and PUBPAT challenged three patents held by WARF because they are hindering stem cell research. Stem Cell Scientist Dr. Jeanne Loring supported the challenge, which led to the rejection of all claims of all three patents in March.

In June WARF offered counter arguments and then in October filed what it described as "technical amendments" to the patent claims.

"Upon review, however, none of those amendments are sufficient to overcome the Examiner's rejections," wrote Daniel B. Ravicher, PUBPAT's executive director. "As such, the claims remain unpatentable."

Read the filing here: http://www.consumerwatchdog.org/resources/913SuppComments.pdf

Four internationally known stem cell scientists, Loring of the Burnham Institute for Medical Research, soon to join the Scripps Research Institute; Dr. Douglas Melton of Harvard University; Dr. Alan Trounson of Monash University in Australia, soon to take over as president of the California Institute for Regenerative Medicine; and Dr. Chad Cowan of Harvard University filed declarations supporting the consumer groups and the PTO's earlier finding that the work done by Dr. James Thomson does not deserve a patent.

WARF holds three stem cell patents, numbers '780, '806 and '913, based on work done by Thomson. The rules applicable to the '913 case under a so-called "inter partes" re-examination allow the challengers to comment on WARF's responses in that proceeding.

The two earlier patents are undergoing "ex parte" re-examination and those rules do not allow formal comment from FTCR and PUBPAT. Nonetheless, the points made by FTCR and PUBPAT in the '913 case are relevant to the other two.

Since the groups filed their challenge, WARF has substantially eased licensing requirements for stem cell researchers

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org and http://www.oilwatchdog.org.

The Public Patent Foundation is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by wrongly issued patents and unsound patent policy. For more information, visit us on the web at http://www.pubpat.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. EntreMed Raises $20 Million to Support Clinical Development Program
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
9. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that ... New Product Innovation Award for Its fibromyalgia pain management ... medical device market research by Frost & Sullivan,s industry experts. ... pain relief product, the AVACEN 100, offers a safe and ... pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology:
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):